Filed: 8/14/2023ACC: 0001420506-23-001711
📋 What this filing means
ALTIUM CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 68 equity positions with a total reported market value of $132.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
68
Positions
$132.12M
Total AUM (reported)
35.10M
Total Shares
Allocation by class
COM$106.55M80.6%
CL A$6.67M5.0%
COM NEW$5.79M4.4%
CLASS A ORD$4.49M3.4%
PUT$3.49M2.6%
CLASS A ORD SHS$1.04M0.8%
*W EXP 07/16/202$776.3K0.6%
Portfolio Concentration
Top 3$32.09M24.3%
4–10$45.45M34.4%
11–25$44.55M33.7%
Rest$10.03M7.6%
Top 3 weight
24.3%
Top 10 weight
58.7%
Voting Authority Distribution
Total shares with voting rights: 35.10M
Sole
Full voting authority
35.10M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole68
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings68
Rows:
CHINOOK THERAPEUTICS INC
SOLEShares305K
TypeSH
Market value$11.72M
8.87%
Sole
305K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares1.35M
TypeSH
Market value$11.22M
8.49%
Sole
1.35M
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares485K
TypeSH
Market value$9.15M
6.93%
Sole
485K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares2.38M
TypeSH
Market value$8.78M
6.65%
Sole
2.38M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares228K
TypeSH
Market value$8.78M
6.64%
Sole
228K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares668.70K
TypeSH
Market value$7.32M
5.54%
Sole
668.70K
Shared
0.00
None
0.00
XTANT MED HLDGS INC
SOLEShares6.23M
TypeSH
Market value$5.79M
4.38%
Sole
6.23M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares149.89K
TypeSH
Market value$5.27M
3.99%
Sole
149.89K
Shared
0.00
None
0.00
GRI BIO INC
SOLEShares1.18M
TypeSH
Market value$5.01M
3.79%
Sole
1.18M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares88K
TypeSH
Market value$4.49M
3.40%
Sole
88K
Shared
0.00
None
0.00
REATA PHARMACEUTICALS INC
SOLEShares41.48K
TypeSH
Market value$4.23M
3.20%
Sole
41.48K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares185K
TypeSH
Market value$3.99M
3.02%
Sole
185K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares2.87M
TypeSH
Market value$3.93M
2.97%
Sole
2.87M
Shared
0.00
None
0.00
INTERCEPT PHARMACEUTICALS IN
SOLEShares323K
TypeSH
Market value$3.57M
2.70%
Sole
323K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares200K
TypeSH
Market value$3.44M
2.60%
Sole
200K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares28K
TypeSH
Market value$3.21M
2.43%
Sole
28K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares130K
TypeSH
Market value$3.02M
2.28%
Sole
130K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares207.43K
TypeSH
Market value$2.97M
2.25%
Sole
207.43K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares40K
TypeSH
Market value$2.87M
2.18%
Sole
40K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares310K
TypeSH
Market value$2.80M
2.12%
Sole
310K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares235K
TypeSH
Market value$2.78M
2.11%
Sole
235K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares135K
TypeSH
Market value$2.43M
1.84%
Sole
135K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares120K
TypeSH
Market value$1.93M
1.46%
Sole
120K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares155K
TypeSH
Market value$1.74M
1.32%
Sole
155K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares1.43M
TypeSH
Market value$1.64M
1.24%
Sole
1.43M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CHINOOK THERAPEUTICS INCSOLE | COM | 305K | SH | $11.72M 8.87% | 305K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 1.35M | SH | $11.22M 8.49% | 1.35M | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 485K | SH | $9.15M 6.93% | 485K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 2.38M | SH | $8.78M 6.65% | 2.38M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 228K | SH | $8.78M 6.64% | 228K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 668.70K | SH | $7.32M 5.54% | 668.70K | 0.00 | 0.00 |
XTANT MED HLDGS INCSOLE | COM NEW | 6.23M | SH | $5.79M 4.38% | 6.23M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 149.89K | SH | $5.27M 3.99% | 149.89K | 0.00 | 0.00 |
GRI BIO INCSOLE | COM | 1.18M | SH | $5.01M 3.79% | 1.18M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 88K | SH | $4.49M 3.40% | 88K | 0.00 | 0.00 |
REATA PHARMACEUTICALS INCSOLE | CL A | 41.48K | SH | $4.23M 3.20% | 41.48K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 185K | SH | $3.99M 3.02% | 185K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM | 2.87M | SH | $3.93M 2.97% | 2.87M | 0.00 | 0.00 |
INTERCEPT PHARMACEUTICALS INSOLE | COM | 323K | SH | $3.57M 2.70% | 323K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | PUT | 200K | SH | $3.44M 2.60% | 200K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 28K | SH | $3.21M 2.43% | 28K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 130K | SH | $3.02M 2.28% | 130K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 207.43K | SH | $2.97M 2.25% | 207.43K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 40K | SH | $2.87M 2.18% | 40K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 310K | SH | $2.80M 2.12% | 310K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 235K | SH | $2.78M 2.11% | 235K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 135K | SH | $2.43M 1.84% | 135K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 120K | SH | $1.93M 1.46% | 120K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 155K | SH | $1.74M 1.32% | 155K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 1.43M | SH | $1.64M 1.24% | 1.43M | 0.00 | 0.00 |
Page 1 of 3